Want to join the conversation?
$NP said that at the end of 1Q16, debt was $239MM and debt-to-EBITDA ratio was around 1.5 with over $100MM of borrowing capacity available on existing credit facilities. The company's effective tax rate was 33% vs. 37% reported in 1Q15. The lower rate is largely due to differences in timing of R&D credits recognized all at once in 4Q15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?